If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

Share Price is delayed by 15 minutes
Get Live Data
79.00    -2.00 (-2.47%)
Bid:
78.00
Ask:
80.00
Spread: 2.00 (2.564%)
Market Cap: £11.46m
RBD Live PriceLast checked at - London Stock Exchange

Intraday Reabold Resources Share Chart

Directors' Dealings and Options Exercise

29 Mar 2010 16:44

RNS Number : 3688J
Adventis Group PLC
29 March 2010
 



29 March 2010

 

Adventis Group Plc ("Adventis", the "Group" or the "Company")

 

Issue of new shares and directors' dealings

 

Adventis Group plc (Adventis - ATG), the AIM-quoted full service multimedia marketing and advertising agency, announces the issue of 350,000 ordinary shares of 0.25p each in the Company ("New Ordinary Shares") to Charles Phillpot a director of the Company, pursuant to options granted on 20 October 2006 under the 2006 Long Term Incentive Plan that vested in full in October 2009.

 

Application has been made for the admission to trading on AIM of the New Ordinary Shares ("Admission") which will, upon Admission, rank pari passu with the Company's existing issued ordinary shares. Dealings are expected to commence on 30 March 2010.

 

Directors' dealings

 

The Company also announces that Charles Phillpot has today sold 150,000 ordinary 0.25p shares in the Company ("Shares") at a price of 18.5p per Share in order to raise the funds required to settle the tax and national insurance liabilities arising on the receipt of 350,000 New Ordinary Shares.

 

Following (i) the sale of these Shares and (ii) the issue of the New Ordinary shares, Charles Phillpot will hold 1,694,000 Shares representing approximately 3.57% of the total enlarged number of voting rights of the Company following Admission.

 

Aubrey Adams, also a director of the Company, has today acquired 250,000 Shares at a price of 18.5p per Share, and now holds 1,000,000 Shares, representing approximately 2.11% of the total enlarged number of voting rights of the Company following Admission.

 

Total Voting Rights

 

In accordance with the FSA's Disclosure and Transparency Rules, the Company notifies the market of the following:

 

Following Admission of the 350,000 New Ordinary Shares on 30 March 2010 the Company's issued share capital will comprise 48,217,471 ordinary shares with a nominal value of 0.25p each, with voting rights. The Company will hold 728,953 Shares in Treasury.

 

Therefore the total number of Shares in the Company with voting rights will be 47,488,518.

 

The above figure of 47,488,518 Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

-ENDS-

 

 

Enquiries:

 

 

Adventis Group Plc

Charles Phillpot, CEO

020 7034 4750

Peter Linnell, Finance Director

020 7034 4795

Arbuthnot Securities Limited

Tom Griffiths

020 7012 2000

 

 

Notes to Editors:

 

Adventis Group is a marketing services and advertising agency. Its core areas of activity are healthcare, technology & telecoms, media and property. Subsidiary companies include: Adventis Health, Second2, bChannels, Adventis Media and Adventis Property.

For full details see www.adventis.co.uk

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSPGUWCWUPUGAB
Date   Source Headline
12th Jan 20267:00 amRNSStandard form for notification of major holdings
8th Jan 20267:00 amRNSPublication of Favourable Formal Decree
24th Dec 20257:00 amRNSStandard form for notification of major holdings
14th Nov 20257:00 amRNS-RReabold launches new interactive investor hub
24th Oct 20257:00 amRNSDanube - Parta Licence Update
10th Oct 20257:00 amRNSFurther Investment into LNEnergy
7th Oct 20257:56 amRNS€16 Million Earn Out Agreed for Colle Santo
30th Sep 20257:00 amRNSUnaudited Interim Results
26th Aug 20257:00 amRNSKey Regulatory Milestone Achieved for Colle Santo
7th Aug 20257:00 amRNSOperations Update on West Newton
11th Jul 20251:11 pmRNSResults of Annual General Meeting
16th Jun 202512:31 pmRNSDirector/PDMR Dealings
13th Jun 20254:02 pmRNSPublication of Annual Report and Notice of AGM
13th Jun 202511:57 amRNSDeferred Annual Bonus Plan 2024 Share Option Award
11th Jun 20257:00 amRNSFY Results for the year ended 31 December 2024
8th May 20257:24 amRNSConversion of Loan Notes
26th Mar 20257:00 amRNSUpdate on Colle Santo, Italy
17th Mar 20257:00 amRNSAppointment of NED to the Board of Rathlin Energy
4th Mar 202510:10 amRNSHolding(s) in Company
4th Mar 202510:09 amRNSHolding(s) in Company
31st Jan 20257:00 amRNSCompletion of Further Investment in Rathlin Energy
30th Jan 20257:00 amRNSLNEnergy Option Extension
12th Dec 20247:00 amRNSFurther investment in Rathlin Energy
24th Oct 20247:00 amRNSConversion of Loan Notes
8th Oct 20247:00 amRNSChange of Nominated Adviser
26th Sep 20247:00 amRNSUnaudited Interim Results
24th Sep 20247:00 amRNSWest Newton Update
20th Aug 20247:00 amRNSLNEnergy Update
28th Jun 202411:47 amRNSResult of AGM
17th Jun 202411:15 amRNSDirector/PDMR Dealing
14th Jun 20247:00 amRNSDirector/PDMR Shareholding
13th Jun 20247:00 amRNSWest Newton Update
6th Jun 202410:35 amRNSDeferred Annual Bonus Plan Shares Option Awards
4th Jun 20247:00 amRNSPublication of Annual Report and Notice of AGM
31st May 20247:00 amRNSFY Results for the year ended 31 December 2023
24th May 20247:00 amRNSWest Newton awarded AA rating for Carbon Intensity
9th May 20247:00 amRNSChange of Broker
2nd May 20247:00 amRNSHoA Signed between Gunvor and LNEnergy
27th Feb 20247:00 amRNSOperational and Corporate Update
20th Feb 20247:00 amRNSInvestor Presentation
18th Jan 20247:00 amRNSNotification of final tranche of Shell payment
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 202411:47 amRNSResult of Requisitioned General Meeting
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20243:40 pmRNSUpdate re Requisitioned General Meeting
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.